載入...
Mitochondrial apoptosis and BH3 mimetics
The BCL2-selective BH3 mimetic venetoclax was recently approved for the treatment of relapsed, chromosome 17p-deleted chronic lymphocytic leukemia (CLL) and is undergoing extensive testing, alone and in combination, in lymphomas, acute leukemias, and solid tumors. Here we summarize recent advances i...
Na minha lista:
| 發表在: | F1000Res |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
F1000Research
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5133681/ https://ncbi.nlm.nih.gov/pubmed/27990281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.9629.1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|